Detalhe da pesquisa
1.
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adults.
Cephalalgia
; 44(2): 3331024231219505, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366390
2.
No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults.
Clin Transl Sci
; 17(3): e13727, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38440916
3.
Effects of intravenous oxycodone alone or in combination with naltrexone on measures of respiratory depression: a randomized placebo-controlled study.
Ther Adv Drug Saf
; 10: 2042098618821274, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30746121
4.
Distribution, Metabolism, and Excretion of Gedatolisib in Healthy Male Volunteers After a Single Intravenous Infusion.
Clin Pharmacol Drug Dev
; 8(1): 22-31, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30256541